Are there clinical trials suitable for treating recurrent Pancreatic Cancer, and how can I determine if I am eligible
According to the National Cancer Institute (NCI), clinical trials are often particularly important for pancreatic cancer patients with recurrent disease, as they may provide access to new treatments that aren't yet widely available.
The NCCN Guidelines for Pancreatic Cancer (2023 version) specifically recommend that:
- Clinical trial participation should be strongly considered at any stage of pancreatic cancer treatment
- Clinical trials are particularly encouraged for patients with recurrent disease who have good performance status (ability to carry out daily activities)
The American Society of Clinical Oncology (ASCO) guidelines outline several key factors that determine clinical trial eligibility:
- Previous treatments received
- Overall health status/performance status
- Specific genetic mutations in your tumor (if known)
- Time since last treatment
- Organ function measurements
To find and determine eligibility for clinical trials, here are the recommended steps:
-
Start by discussing clinical trials with your oncologist, as they can often directly connect you with appropriate trials at their institution
-
Use these trusted resources to search for trials:
- NCI's clinical trial finder (www.cancer.gov/clinicaltrials)
- Pancreatic Cancer Action Network's Clinical Trial Finder
- ClinicalTrials.gov
Remember that eligibility criteria can be complex, and your healthcare team is best positioned to help determine which trials might be appropriate for your specific situation. They can review your complete medical history, current health status, and prior treatments to match you with suitable trials.
I encourage you to:
- Gather your most recent [ID removed] and treatment history
- Make an appointment with your oncologist to specifically discuss clinical trial options
- Consider getting a second opinion at a major cancer center that may have access to additional trials
Would you like me to provide more specific information about any of these aspects of clinical trial participation?
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Pancreatic Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Pancreatic Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Pancreatic Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Pancreatic Cancer
- How do I find clinical trials for stage 4 pancreatic cancer near Boston
- Is recurrent Pancreatic Cancer harder to treat than the original
- What should I consider when choosing between clinical trial and standard treatment for Pancreatic Cancer
- How effective is gemcitabine (Gemzar) for treating Pancreatic Cancer
- What is the role of PARP inhibitors in treating Pancreatic Cancer
- What is the role of radiation therapy in treating Pancreatic Cancer
- Are there promising clinical trials I should consider at this stage, or potentially as a next step
- Provide more specific information about any current clinical trials involving proteomics testing for pancreatic cancer